About Us
Services
Microbiome LBP Manufacturing
Process & Formulation Development
Analytical Development & QC
Clinical + Commercial Manufacturing
mRNA Vaccine Manufacturing
Process Development & Characterization
Analytical Development & QC
Clinical + Commercial Manufacturing
Plasmid Manufacturing
Process & Analytical Development
Quality & Regulatory Support
Program Management
Custom Biomanufacturing Solutions
Facilities
Careers
Working at Arranta
Training & Benefits
Internships
Browse Opportunities & Apply
Contact Us
Menu
Menu
News
Resources
Request More Information
News
Filter by:
Select
Events
News
Press Release
Press Release
January 30, 2020
Arranta Bio announces key leadership additions of Chief Operations Officer and SVP of Business Development as it commits to a $100M investment in building end-to-end microbiome capacity
Read More
Press Release
November 13, 2019
Arranta Bio announces the acquisition of Captozyme™, creating a Center of Excellence for microbiome development and clinical supply
Read More
Press Release
October 29, 2019
Arranta Bio announces $82M in new funding, and a strategic partnership with Thermo Fisher Scientific
Read More
‹
1
2
3
4
